Novaestiq
Novaestiq is a startup headquartered in Southlake, United States, founded in 2021. It has raised at least $7.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Novaestiq has raised at least $7.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Novaestiq sits inside the Dallas R&D ecosystem in the Global R&D Labs Directory.
Other startups in Southlake
Related
- Innovation profile of Southlake
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Novaestiq do?
Novaestiq is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Novaestiq raised?
At least $7.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Novaestiq based?
Novaestiq is headquartered in Southlake, United States.
When was Novaestiq founded?
Novaestiq was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.